Breaking News on Contract Research, Manufacturing & Clinical Trials

Big Sponsors > Amgen

Amgen selects Patheon as a 'strategic' manufacturing partner

15-Mar-2016 - The flexible manufacturing deal with Amgen is a departure from the standard transactional contract approach, according to Patheon.

Bear-faced lie? Amgen retracts diabetes-obesity paper due to data manipulation

02-Sep-2015 - Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.

Research consortium looks to identify biomarkers for autism treatments

21-Jul-2015 - A new four-year research project involving a consortium of government, non-profit and other large biopharma partners is aiming to create a set of measures that can be used in clinical...

FDA offers guidance for running early-phase trials for gene, cell therapies

12-Jun-2015 - As the hype continues to hover around the promise of gene and cell therapies, the latest guidance from the FDA will help sponsors, CROs and investigators design early-phase clinical trials...

Sigma-Aldrich opens doors to latest Singapore biopharma investment

22-Apr-2015 - Sigma-Aldrich has opened a cell culture Technical Center in Singapore and plans to expand further in the city-state with a cGMP distribution site.


WuXi to more than double US cell therapy manufacturing ops with new site

12-Mar-2015 - China-based CDMO WuXi PharmaTech unveiled Thursday that it will soon begin construction on its third cell therapy manufacturing facility -- a 145,000-square-foot cGMP facility in Philadelphia. 

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told the preclinical CRO may add scale to US...

CMO use to grow despite Big Biopharma's in-house spend, say experts

02-Dec-2014 - Third-party manufacturers anxious about Big Biopharma investments and downbeat industry reports can relax as experts concur “it’s a time of growth for biopharmaceutical outsourcing.”

Dispatches from PCT

Oversight is key in sponsor-CRO partnerships say Pfizer and Amgen

21-Nov-2013 - Strategic partnerships were put on trial yesterday at PCT and with a number of alliances coming up for renewal, Pfizer, Novartis, Amgen and Baxter spoke about the issues affecting a...

Asian hub’s ambition attracts Amgen into Asia biomanufacture

22-Jan-2013 - The Singapore Economic Development Board (SEDB) says it wants to nurture industry, academic and institutional alliances to attract further global investment in ‘Asia’s fastest growing bio-cluster.’

XD cell culture technology: DSM boosted by Amgen license

17-Jan-2013 - DSM hints at high yield and cost-cutting benefits in licensing its cell growth technology to Amgen.

Boehringer buying Amgen site to expand biologics CMO biz

20-Jan-2011 - Boehringer Ingelheim is to acquire a California, US manufacturing facility from Amgen to expand its contract biologics production capabilities.

Amgen taps Jubilant for drug discovery services

22-Jul-2008 -  India's Jubilant Biosys, a subsidiary of Jubilant Organosys, has scored a major deal with US biotech giant Amgen for the provision of early-stage drug discovery services.  

Oxford Genome Sciences advances on Amgen deal

18-Dec-2007 - Oxford Genome Sciences (OGeS) has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one...

Amgen expounds IL-17 potential as arthritis target

23-Aug-2007 - Amgen is rushing to discover how interleukin-17 causes inflammation and bone destruction in rheumatoid arthritis, as it could provide a valuable new therapeutic target.

Amgen's approach to selectivity predictions

21-Aug-2007 - Amgen has outlined how it uses computer models to predict the selectivity of small molecule drugs.

Amgen posts strong results after Aranesp relief

24-Apr-2007 - Biotech giant Amgen has posted healthy results for the first quarter following a positive performance by its blockbuster anaemia drug Aranesp (darbepoetin alfa).

Amgen to use contract manufacturers for expansion

10-Apr-2007 - Amgen has announced it will increase its reliance on third-party contract manufacturers as part of its ambitious expansion plans.

Amgen evolve Galapagos collaboration

04-Jan-2007 - Galapagos will continue to feed Amgen's drug discovery programmes having expanded the long-standing partnership between the two companies.

Predix and Amgen team up to discover autoimmune drugs

02-Aug-2006 - Predix Phamaceuticals has formed a collaboration with Amgen in a deal that aims to develop S1P1 modulators for the treatment of autoimmune diseases. The agreement has the potential to become...

Amgen expands existing Biovitrum diabetes deal

14-Feb-2006 - Biotechnology company, Amgen, and Biovitrum have expanded its existing license agreement for its treatment of metabolic disorders, focusing on type 2 diabetes, which currently afflicts over 160 million people worldwide.

Amgen's new facilities boosts UK drug R&D

02-Feb-2006 - Amgen are to create a European Development Centre significantly boosting UK drug R&D. The announcement echoes the UK Government's commitment to attract more R&D investment with a view to making...

Amgen adds anaemia drug warning

17-Jan-2005 - The pharmaceutical industry took further damage to its reputation after the Food and Drug Administration (FDA) and healthcare professionals were warned of the anaemia drug Aranesp, after studies on similar...

Key Industry Events


Access all events listing

Our events, Shows & Conferences...